Sign in
SuspendedNo phase

Omnibond vs Dermabond

Key facts

Who runs it
Center for Innovation and Research Organization
Where
New Albany, New York, Philadelphia, and Providence, United StatesSee the 4 sites
Trial code
Status
Suspended
People taking part
310 people, planned
Started
25 Oct 2022
Ended
Feb 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Omnibond Topical Skin Adhesive
  • Dermabond Advanced Topical Skin Adhesive
Record updated
7 February 2024
Why it stopped
Temporarily halted

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patient ≥18 years old
  • Male or non-pregnant, non-lactating, postmenopausal or surgically sterilized females
  • Subjects scheduled to undergo primary, elective total knee arthroplasty or total hip arthroplasty
  • Subjects provide informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information
  • Subjects deemed able to understand and comply with study visit schedule and procedures

Who cannot take part

  • Active or previous infection in the skin or the knee or hip to be operated, evidence of gangrene
  • Subjects who have participated in this trial previously and who were withdrawn
  • Local skin conditions such as dermatitis, eczema, psoriasis that, in the opinion of the investigator, will make it difficult to assess wound complications or local skin reactions following surgery
  • Subjects with known allergies to product components including cyanoacrylate, formaldehyde, benzalkonium chloride or have known allergies or skin sensitivity to the Convatec Aquacel dressing
  • Pregnant, lactating females, or females of childbearing potential not willing to practice an effective method of contraception
  • Inability or refusal to provide informed consent or follow study and wound care instructions

Where in United States

  • JIS OrthopaedicsNew Albany, United States
  • Columbia UniversityNew York, United States
  • Rothman Orthopaedic InstitutePhiladelphia, United States
  • Rhode Island HospitalProvidence, United States

About the trial

What the trial wants to find out

This prospective, randomized, controlled, blinded clinical trial is designed to assess the incidence of all time and all types of wound-related complications following total joint arthroplasty (TJA) when two different types of topical skin adhesives are used to close the incision.

The 2 groups in the trial

  • Omnibond topical skin adhesiveExisting treatment, for comparison
  • Dermabond topical skin adhesiveExisting treatment, for comparison

    Treatment: Dermabond Advanced Topical Skin Adhesive

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Randomized, Single-blinded Study to Assess the Incidence of Wound Complications Following Total Knee and Hip Arthroplasty in Patients Treated With Two Different Types of Topical Skin Adhesive
Record updated
7 February 2024